Nebivolol Teva (Nebivolol Hydrochloride)

Nebivolol selectively blocks β1‑adrenergic receptors in the heart, decreasing heart rate and contractility, which lowers cardiac output and blood pressure. At the same time, it stimulates endothelial nitric‑oxide synthase, causing nitric‑oxide‑mediated vasodilation that reduces peripheral vascular resistance, providing a dual antihypertensive effect.

The exact dose of nebivolol is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and any concomitant medications. Typical starting doses may be low, with gradual titration as needed, but the prescriber sets the final regimen to ensure safety and efficacy.

Limited clinical data are available on nebivolol use during pregnancy and lactation. Because potential risks cannot be ruled out, the drug is generally avoided unless the therapeutic benefit justifies the potential hazard to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Nebivolol Teva. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. After verification, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Nebivolol is distinguished by its high β1‑selectivity and additional nitric‑oxide‑mediated vasodilation, which can result in fewer metabolic side effects and better tolerability compared with non‑selective beta‑blockers. While all beta‑blockers lower heart rate and blood pressure, nebivolol’s vasodilatory property may offer added benefit in patients who experience peripheral fatigue with traditional agents.

Nebivolol tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Do not store in bathrooms or near heat sources. Keep the container tightly closed and out of reach of children.

Nebivolol Teva is taken orally, usually once daily, with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule provided by their healthcare professional and not alter the regimen without medical advice.

Serious adverse events include severe bradycardia, heart block, bronchospasm in patients with asthma or COPD, and rare allergic reactions such as rash or anaphylaxis. Patients should seek immediate medical attention if they experience fainting, marked slowing of the heartbeat, difficulty breathing, or signs of a severe allergic response.

Nebivolol is contraindicated in individuals with known hypersensitivity to nebivolol or any excipients, those with severe bradycardia (heart rate < 45 bpm), advanced atrioventricular block without a pacemaker, and patients in cardiogenic shock. Caution is also advised for patients with uncontrolled asthma, severe hepatic impairment, or those already receiving another beta‑blocker.